EyePoint Pharmaceuticals
EYPT
#6195
Rank
NZ$1.76 B
Marketcap
NZ$21.05
Share price
-2.25%
Change (1 day)
20.77%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -NZ$0.47 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are NZ$7.61 Million. In 2025 the company made an earning of -NZ$0.41 Billion a decrease over its 2024 earnings that were of -NZ$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.47 Billion15.45%
2025 -NZ$0.41 Billion63.24%
2024 -NZ$0.25 Billion104.29%
2023 -NZ$0.12 Billion-29.88%
2022 -NZ$0.18 Billion87.2%
2021 -NZ$91.39 Million38.58%
2020 -NZ$65.95 Million-24.56%
2019 -NZ$87.41 Million
2017 -NZ$39.87 Million22.59%
2016 -NZ$32.52 Million-8.02%
2015 -NZ$35.36 Million-296.09%
2014 NZ$18.02 M-174.02%
2013 -NZ$24.36 Million37.42%
2012 -NZ$17.73 Million-56.29%
2011 -NZ$40.55 Million-1062.38%
2010 NZ$4.21 M-250.43%
2009 -NZ$2.81 Million-89.5%
2008 -NZ$26.69 Million
2005 -NZ$16.46 Million56.99%
2004 -NZ$10.49 Million73.7%
2003 -NZ$6.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.74 Million-99.20% Bahamas
NRC Health
NRC
NZ$33.87 M-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA